Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD

Eur Respir J. 2014 Jun;43(6):1818-9. doi: 10.1183/09031936.00036314.

Authors

Katia M C Verhamme¹, Miriam C J M Sturkenboom², Guy G O Brusselle³

Affiliations

¹ Erasmus Medical Center, Dept of Medical Informatics, Rotterdam, The Netherlands [email protected].
² Erasmus Medical Center, Dept of Medical Informatics, Rotterdam, The Netherlands.
³ Ghent University Hospital, Dept of Respiratory Medicine, Ghent, Belgium Erasmus Medical Center, Dept of Epidemiology, Rotterdam, The Netherlands.

PMID: 24881063
DOI: 10.1183/09031936.00036314

No abstract available

Publication types

Letter
Comment

MeSH terms

Bronchodilator Agents / administration & dosage*
Drug Delivery Systems / adverse effects*
Dry Powder Inhalers / adverse effects*
Female
Humans
Male
Pulmonary Disease, Chronic Obstructive / drug therapy*
Scopolamine Derivatives / administration & dosage*

Substances

Bronchodilator Agents
Scopolamine Derivatives